01.11.2004
Alendronate reduces serum TNFα and IL-1β, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis
Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 6/2004
Einloggen, um Zugang zu erhalten